Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin Lymphoma.
Lupia T, Crisà E, Gaviraghi A, Rizzello B, Di Vincenzo A, Carnevale-Schianca F, Caravelli D, Fizzotti M, Tolomeo F, Vitolo U, De Benedetto I, Shbaklo N, Cerutti A, Fenu P, Gregorc V, Corcione S, Ghisetti V, De Rosa FG. Lupia T, et al. Among authors: gregorc v. Trop Med Infect Dis. 2023 Jun 20;8(6):331. doi: 10.3390/tropicalmed8060331. Trop Med Infect Dis. 2023. PMID: 37368749 Free PMC article.
Overlapping Infection by Strongyloides spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the Literature.
Lupia T, Crisà E, Gaviraghi A, Rizzello B, Di Vincenzo A, Carnevale-Schianca F, Caravelli D, Fizzotti M, Tolomeo F, Vitolo U, De Benedetto I, Shbaklo N, Cerutti A, Fenu P, Gregorc V, Corcione S, Ghisetti V, De Rosa FG. Lupia T, et al. Among authors: gregorc v. Trop Med Infect Dis. 2023 Jul 10;8(7):358. doi: 10.3390/tropicalmed8070358. Trop Med Infect Dis. 2023. PMID: 37505654 Free PMC article. Review.
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series.
Longo BM, Venuti F, Gaviraghi A, Lupia T, Ranzani FA, Pepe A, Ponzetta L, Vita D, Allice T, Gregorc V, Frascione PMM, De Rosa FG, Calcagno A, Bonora S. Longo BM, et al. Among authors: gregorc v. Antibiotics (Basel). 2023 Sep 19;12(9):1460. doi: 10.3390/antibiotics12091460. Antibiotics (Basel). 2023. PMID: 37760757 Free PMC article.
Stenotrophomonas maltophilia Infections in Haematological Malignancies and Hematopoietic Stem Cell Transplantation: A Case Series including Cefiderocol-Based Regimens.
Lupia T, Carnevale-Schianca F, Vita D, Busca A, Caravelli D, Crisà E, Gregorc V, Curtoni A, Cerutti A, Shbaklo N, Corcione S, De Rosa FG. Lupia T, et al. Among authors: gregorc v. Medicina (Kaunas). 2024 Jan 3;60(1):88. doi: 10.3390/medicina60010088. Medicina (Kaunas). 2024. PMID: 38256349 Free PMC article.
CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches.
Tang J, Zheng Q, Wang Q, Zhao Y, Ananthanarayanan P, Reina C, Šabanović B, Jiang K, Yang MH, Meny CC, Wang H, Agerbaek MØ, Clausen TM, Gustavsson T, Wen C, Borghi F, Mellano A, Fenocchio E, Gregorc V, Sapino A, Theander TG, Fu D, Aicher A, Salanti A, Shen B, Heeschen C. Tang J, et al. Among authors: gregorc v. Cell Rep Med. 2024 Sep 17;5(9):101692. doi: 10.1016/j.xcrm.2024.101692. Epub 2024 Aug 19. Cell Rep Med. 2024. PMID: 39163864 Free PMC article.
Exploring machine learning tools in a retrospective case-study of patients with metastatic non-small cell lung cancer treated with first-line immunotherapy: A feasibility single-centre experience.
Ogliari FR, Traverso A, Barbieri S, Montagna M, Chiabrando F, Versino E, Bosco A, Lin A, Ferrara R, Oresti S, Damiano G, Viganò MG, Ferrara M, Riva ST, Nuccio A, Venanzi FM, Vignale D, Cicala G, Palmisano A, Cascinu S, Gregorc V, Bulotta A, Esposito A, Tacchetti C, Reni M. Ogliari FR, et al. Among authors: gregorc v. Lung Cancer. 2024 Dec 31;199:108075. doi: 10.1016/j.lungcan.2024.108075. Online ahead of print. Lung Cancer. 2024. PMID: 39752796
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model.
Parab S, Sarlo V, Capellero S, Palmiotto L, Bartolini A, Cantarella D, Turi M, Gullà A, Grassi E, Lazzari C, Rubatto M, Gregorc V, Carnevale-Schianca F, Olivero M, Bussolino F, Comunanza V. Parab S, et al. Among authors: gregorc v. Int J Mol Sci. 2024 Oct 18;25(20):11228. doi: 10.3390/ijms252011228. Int J Mol Sci. 2024. PMID: 39457009 Free PMC article.
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.
Spicer JD, Garassino MC, Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Arunachalam A, Keller SM, Samkari A, Gao S; KEYNOTE-671 Investigators. Spicer JD, et al. Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14. Lancet. 2024. PMID: 39288781 Clinical Trial.
114 results